The first week of 2024 saw significant stock price appreciation for most of the 30 stocks Viridian Capital Advisors credit ranks weekly. As a proxy, the MSOS ETV rose 12.84%, the sharpest uptick since the HHS announcement at the end of August. There was no particular news to account for the uptick except for confirmation from the DEA that they are indeed studying the issue of rescheduling.
Morgan Stanley looked at the clean tech sector, predicting lower interest rates and deflation of core techs in 2024. They upgraded First Solar and highlighted 4 stocks with Overweight ratings, and 2 with Underweight ratings.
In the world of high technology, the most attention-grabbing events are not always the most important or game-changing ones. Today's headlines revolve around the adoption of ETFs, the trial involving SBF, regulations, new FCA norms, the end of the crypto winter, and the start of a bullish cycle.